{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:21Z","timestamp":1794047421929,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"8","license":[{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2022.282394","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T03:23:46Z","timestamp":1674098626000},"page":"2229-2233","source":"Crossref","is-referenced-by-count":3,"title":["TIM3, a human acute myeloid leukemia stem cell marker, does not enrich for leukemia-initiating stem cells in B-cell acute lymphoblastic leukemia"],"prefix":"10.3324","volume":"108","author":[{"given":"Clara","family":"Bueno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Alejandra","family":"Romecin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanta Romina","family":"Zanetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky","family":"Tirtakusuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulalia","family":"Genesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Cam\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ram\u00edrez-Orellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Anguita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ballerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"key":"50783","doi-asserted-by":"crossref","unstructured":"Ishikawa F, Yoshida S, Saito Y. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol. 2007; 25(11):1315-1321.","DOI":"10.1038\/nbt1350"},{"key":"50784","doi-asserted-by":"crossref","unstructured":"Hoang VT, Zepeda-Moreno A, Ho AD. Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance. Biotechnol J. 2012; 7(6):779-788.","DOI":"10.1002\/biot.201100350"},{"key":"50785","doi-asserted-by":"crossref","unstructured":"Mohamed MMI, Aref S, Agdar MA, Mabed M, El-Sokkary AMA. Leukemic stem cell (CD34(+)\/CD38(-)\/TIM3(+)) frequency in patients with acute myeloid leukemia: clinical implications. Clin Lymphoma Myeloma Leuk. 2021; 21(8):508-513.","DOI":"10.1016\/j.clml.2021.03.009"},{"key":"50786","doi-asserted-by":"crossref","unstructured":"Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997; 3(7):730-737.","DOI":"10.1038\/nm0797-730"},{"key":"50787","doi-asserted-by":"crossref","unstructured":"Ding Y, Gao H, Zhang Q. The biomarkers of leukemia stem cells in acute myeloid leukemia. Stem Cell Investig. 2017; 4:19.","DOI":"10.21037\/sci.2017.02.10"},{"key":"50788","doi-asserted-by":"crossref","unstructured":"Jaiswal S, Jamieson CH, Pang WW. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 2009; 138(2):271-285.","DOI":"10.1016\/j.cell.2009.05.046"},{"key":"50789","doi-asserted-by":"crossref","unstructured":"Jin L, Lee EM, Ramshaw HS. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells. Cell Stem Cell. 2009; 5(1):31-42.","DOI":"10.1016\/j.stem.2009.04.018"},{"key":"50790","doi-asserted-by":"crossref","unstructured":"van Rhenen A, van Dongen GA, Kelder A. The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells. Blood. 2007; 110(7):2659-2666.","DOI":"10.1182\/blood-2007-03-083048"},{"key":"50791","doi-asserted-by":"crossref","unstructured":"Jan M, Chao MP, Cha AC. Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker. Proc Natl Acad Sci U S A. 2011; 108(12):5009-5014.","DOI":"10.1073\/pnas.1100551108"},{"key":"50792","doi-asserted-by":"crossref","unstructured":"Bosch M, Sanchez-Alvarez M, Fajardo A. Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense. Science. 2020; 370(6514)","DOI":"10.1126\/science.aay8085"},{"key":"50793","doi-asserted-by":"crossref","unstructured":"Rezaei M, Tan J, Zeng C, Li Y, Ganjalikhani-Hakemi M. TIM-3 in leukemia; immune response and beyond. Front Oncol. 2021; 11:753677.","DOI":"10.3389\/fonc.2021.753677"},{"key":"50794","doi-asserted-by":"crossref","unstructured":"Tirtakusuma R, Szoltysek K, Milne P. Epigenetic regulator genes direct lineage switching in MLL\/AF4 leukaemia. Blood. 2022; 140(17):1875-1890.","DOI":"10.1182\/blood.2021015036"},{"key":"50795","doi-asserted-by":"crossref","unstructured":"Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009; 347(1-2):70-78.","DOI":"10.1016\/j.jim.2009.06.008"},{"key":"50796","doi-asserted-by":"crossref","unstructured":"Prieto C, Lopez-Millan B, Roca-Ho H. NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL. Leukemia. 2018; 32(3):633-644.","DOI":"10.1038\/leu.2017.294"},{"key":"50797","doi-asserted-by":"crossref","unstructured":"le Viseur C, Hotfilder M, Bomken S. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell. 2008; 14(1):47-58.","DOI":"10.1016\/j.ccr.2008.05.015"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282394\/75216","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282394\/75900","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10943\/75216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:03:12Z","timestamp":1794045792000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.282394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":15,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.282394","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,19]]}}}